ONC publishes wave six of 2014 draft test procedures

Luke Gale | | Health Exec | Policy & Regulations

The Office of the National Coordinator for Health IT (ONC) released wave six of the draft test procedures for the 2014 edition of EHR certification criteria and is inviting the public to comment.

The procedures, scheduled to be finalized and published in early 2013, are intended for use by testing laboratories and certification bodies authorized by the ONC HIT Program to validate EHR systems’ compliance with standards established by the Department of Health and Human Services. Wave five of the draft test procedures were published Oct. 18.

Public comments on the wave six draft test procedures are welcome through the two weeks following their publication date, Nov. 2. Specific criterion are listed on the ONC website and include:

  • Automated numerator recording;
  • Automated measure calculation;
  • Capture and export clinical quality measures;
  • Import and calculate clinical quality measures; and
  • Electronic submission of clinical quality measures.

Luke Gale

Related Content

More than 1,000 hospitals earn $700M opioid crisis judgment
VA planning 83,000 layoffs as part of restructuring
HIMSS survey report: Beware insider threats to cybersecurity involving AI
HHS spokesperson abruptly resigns, reportedly after clash with RFK
Hospital faces $3.5M settlement after sharing patient data with Facebook
Philips pulls endovascular devices from market after safety issues prompt Class I recall

Around the web

Cardiovascular Business
Boston Scientific enters renal denervation market with acquisition worth up to $540M

Boston Scientific has announced another significant M&A deal, scooping up an Israeli medtech company focused on RDN technology. 

Radiology Business
Shift toward imaging outside the hospital could save billions

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Cardiovascular Business
FDA announces catheter recall for Johnson & Johnson PFA system due to stroke risk

The recall comes after approximately 3% of patients treated with the device during the early stages of its U.S. rollout experienced a stroke or transient ischemic attack following surgery. The expected stroke rate is closer to 1%, the FDA explained.